IL148008A0 - Conditional immortalisation of cells - Google Patents
Conditional immortalisation of cellsInfo
- Publication number
- IL148008A0 IL148008A0 IL14800800A IL14800800A IL148008A0 IL 148008 A0 IL148008 A0 IL 148008A0 IL 14800800 A IL14800800 A IL 14800800A IL 14800800 A IL14800800 A IL 14800800A IL 148008 A0 IL148008 A0 IL 148008A0
- Authority
- IL
- Israel
- Prior art keywords
- cells
- recombinant
- conditional immortalisation
- immortalisation
- conditional
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99307405 | 1999-09-17 | ||
US09/663,537 US6399384B1 (en) | 1999-09-17 | 2000-09-15 | Conditional immortalization of cells |
PCT/GB2000/003588 WO2001021790A1 (en) | 1999-09-17 | 2000-09-18 | Conditional immortalisation of cells |
Publications (1)
Publication Number | Publication Date |
---|---|
IL148008A0 true IL148008A0 (en) | 2002-09-12 |
Family
ID=26153574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14800800A IL148008A0 (en) | 1999-09-17 | 2000-09-18 | Conditional immortalisation of cells |
Country Status (11)
Country | Link |
---|---|
US (1) | US6399384B1 (xx) |
EP (1) | EP1212420B1 (xx) |
JP (1) | JP2003510046A (xx) |
CN (1) | CN1373804A (xx) |
AT (1) | ATE297987T1 (xx) |
AU (1) | AU757816B2 (xx) |
CA (1) | CA2383253A1 (xx) |
DE (1) | DE60020855T2 (xx) |
ES (1) | ES2241652T3 (xx) |
IL (1) | IL148008A0 (xx) |
WO (1) | WO2001021790A1 (xx) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9518606D0 (en) * | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
GB9907243D0 (en) * | 1999-03-29 | 1999-05-26 | Reneuron Ltd | Therapy |
GB0005856D0 (en) * | 2000-03-10 | 2000-05-03 | Reneuron Ltd | Genetic constructs |
DE10019195B4 (de) * | 2000-04-17 | 2006-03-09 | Heart Biosystems Gmbh | Reversible Immortalisierung |
US20040170955A1 (en) * | 2000-09-08 | 2004-09-02 | Wadih Arap | Human and mouse targeting peptides identified by phage display |
US7452964B2 (en) | 2001-09-07 | 2008-11-18 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides against placenta and adipose tissues |
US7420030B2 (en) | 2000-09-08 | 2008-09-02 | The Board Of Regents Of The University Of Texas System | Aminopeptidase A (APA) targeting peptides for the treatment of cancer |
US20050074747A1 (en) * | 2000-09-08 | 2005-04-07 | Wadih Arap | Biopanning and rapid analysis of selective interactive ligands (brasil) |
EP1207196A1 (en) * | 2000-10-27 | 2002-05-22 | Societe Des Produits Nestle S.A. | Immortalized preosteoblasts and method for their production |
EP1418932A4 (en) * | 2001-07-18 | 2006-03-15 | Univ Texas | ANTI-ANGIOGENIC STATE IN MOUSE AND HUMAN BEINGS SUFFERING FROM CELL DEGENERATION OF THE RETINAL PHOTORECEPTOR |
US8507445B2 (en) * | 2001-09-07 | 2013-08-13 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
US7671010B2 (en) * | 2002-08-30 | 2010-03-02 | The Board Of Regents Of The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
US20040048243A1 (en) * | 2001-09-07 | 2004-03-11 | Wadih Arap | Methods and compositions for in vitro targeting |
GB0125773D0 (en) * | 2001-10-26 | 2001-12-19 | Reneuron Ltd | Constructs |
JPWO2003038076A1 (ja) * | 2001-10-31 | 2005-02-24 | 株式会社レノメディクス研究所 | 不死化間葉系細胞及びその利用 |
DE60334533D1 (de) * | 2002-03-15 | 2010-11-25 | Univ Duke | Gewebe-engineering |
AU2004231094A1 (en) * | 2003-04-14 | 2004-10-28 | Board Of Regents, The University Of Texas System | Methods for ex vivo hybridoma-free production of polyclonal and monoclonal antibodies and generation of immortalized cell populations |
AU2004272340B2 (en) * | 2003-09-12 | 2008-01-03 | Dana Farber Cancer Institute | Immortalisation of mammalian cells and therapeutic applications of said cells |
US20050193432A1 (en) * | 2003-11-18 | 2005-09-01 | Whitehead Institute For Biomedical Research | Xenograft model of functional normal and malignant human breast tissues in rodents and methods thereof |
DK1645626T3 (da) * | 2004-09-30 | 2008-01-21 | Reneuron Ltd | Cellelinie |
US20090298095A1 (en) * | 2005-04-15 | 2009-12-03 | The John Hopkins University | Immortalization of cells including neuronal cells |
NZ569816A (en) * | 2005-12-16 | 2011-10-28 | Ribovax Biotechnologies Sa | Methods for obtaining immortalized antibody secreting cells |
GB0822246D0 (en) | 2008-12-05 | 2009-01-14 | Reneuron Ltd | Composition |
GB0902034D0 (en) | 2009-02-06 | 2009-03-11 | Reneuron Ltd | Method |
EP2380905A1 (en) | 2010-04-19 | 2011-10-26 | Thrombotargets Europe, S.L. | Phospholipid-enriched vesicles bearing tissue factor having haemostatic activities and uses thereof |
CN105176913A (zh) * | 2015-09-23 | 2015-12-23 | 扬州大学 | 一种奶牛乳腺上皮细胞永生化方法 |
JP2022513490A (ja) * | 2018-12-16 | 2022-02-08 | フィジーン、エルエルシー | 遺伝子編集線維芽細胞の治療的使用 |
GB202005494D0 (en) | 2020-04-15 | 2020-05-27 | Reneuron Ltd | Induced pluripotent cell comprising a contollable transgene for conditional immortalisation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270191A (en) * | 1988-04-12 | 1993-12-14 | Massachusetts Institute Of Technology | Method for manipulation of the cell types of eukaryotes |
US5766948A (en) | 1993-01-06 | 1998-06-16 | The Regents Of The University Of California | Method for production of neuroblasts |
EP0799315A2 (en) | 1994-12-19 | 1997-10-08 | Cold Spring Harbor Laboratory | Telomerase protein component |
GB9518606D0 (en) | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
DE69739497D1 (de) * | 1996-10-01 | 2009-08-27 | Geron Corp | Menschlische Telomerase katalytische Untereinheit |
WO1998037181A2 (en) | 1997-02-20 | 1998-08-27 | Whitehead Institute For Biomedical Research | Telomerase catalytic subunit gene and encoded protein |
-
2000
- 2000-09-15 US US09/663,537 patent/US6399384B1/en not_active Expired - Fee Related
- 2000-09-18 AU AU73015/00A patent/AU757816B2/en not_active Ceased
- 2000-09-18 JP JP2001525348A patent/JP2003510046A/ja active Pending
- 2000-09-18 AT AT00960846T patent/ATE297987T1/de not_active IP Right Cessation
- 2000-09-18 CA CA002383253A patent/CA2383253A1/en not_active Abandoned
- 2000-09-18 IL IL14800800A patent/IL148008A0/xx unknown
- 2000-09-18 EP EP00960846A patent/EP1212420B1/en not_active Expired - Lifetime
- 2000-09-18 DE DE60020855T patent/DE60020855T2/de not_active Expired - Lifetime
- 2000-09-18 ES ES00960846T patent/ES2241652T3/es not_active Expired - Lifetime
- 2000-09-18 WO PCT/GB2000/003588 patent/WO2001021790A1/en active IP Right Grant
- 2000-09-18 CN CN00812878A patent/CN1373804A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2383253A1 (en) | 2001-03-29 |
AU7301500A (en) | 2001-04-24 |
JP2003510046A (ja) | 2003-03-18 |
EP1212420B1 (en) | 2005-06-15 |
DE60020855D1 (de) | 2005-07-21 |
US6399384B1 (en) | 2002-06-04 |
CN1373804A (zh) | 2002-10-09 |
ES2241652T3 (es) | 2005-11-01 |
AU757816B2 (en) | 2003-03-06 |
DE60020855T2 (de) | 2006-05-04 |
ATE297987T1 (de) | 2005-07-15 |
WO2001021790A1 (en) | 2001-03-29 |
EP1212420A1 (en) | 2002-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL148008A0 (en) | Conditional immortalisation of cells | |
AU4221399A (en) | Human cd45+ and/or fibroblast + mesenchymal stem cells | |
IL148060A0 (en) | Compositions and methods for improved cell culture | |
IL148512A0 (en) | Methods for making recombinant proteins using apoptosis inhibitors | |
IL137946A0 (en) | Intracardiac cell delivery and cell transplantation | |
WO1998006747A3 (en) | Uses for wnt polypeptides | |
MXPA03007829A (es) | Catodos de pila de combustible novedosos y sus pilas de combustible. | |
EP0953354A4 (en) | HEMATOPOIETIC STEM CELLS PROLIFERING ACTIVE SUBSTANCES | |
EP0456640A4 (en) | GENETICALLY GENERATED ENDOTHEL CELLS AND THEIR USE. | |
IL144654A0 (en) | Pancreatic progenitor cells, methods and uses related thereto | |
GB2392674B (en) | Mesenchymal cells and osteoblasts from human embryonic stem cell | |
MXPA02004882A (es) | Genes de desarrollo de la planta. | |
EP1439226A3 (en) | A nucleic acid antisense sequence to a polynucleotide encoding a polypeptide having heparanese activity | |
AU9582398A (en) | Methods and devices for the long-term culture of hematopoietic progenitor cells | |
MXPA02003733A (es) | Metodos para producir celulas progenitoras diferenciadas y celulas troncales embrionicas de lineas de descendencia defectivas. | |
EP1447443A4 (en) | IMMORTALIZED MESENCHYMAL CELLS AND USE THEREOF | |
ATE342275T1 (de) | Vorübergehend-immortalisierte zellen zur verwendung in gentherapie | |
EP1157118A4 (en) | POLYNUCLEOTID ENCODING A POLYPEPTIDE WITH HEPARANASE ACTIVITY AND ITS EXPRESSION IN GENETICALLY MODIFIED CELLS | |
EP1233058A4 (en) | PROCESS FOR THE REPRODUCTION OF NATURAL KILLER CELLS | |
GB9825096D0 (en) | Cells,culture methods and their uses | |
ATE226087T1 (de) | Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon | |
AU2002303277A1 (en) | Artificial chromosomes that can shuttle between bacteria, yeast, and mammalian cells | |
MXPA02002653A (es) | Clonacion de cerdos usando celulas donadoras o nucleos a partir de celulas diferenciadas y produccion de porcinos pluripotentes. | |
DE69737597D1 (de) | Vektoren zur inhibierung von viralem und tumorwachstum | |
ZA200202481B (en) | Recombinant adenoviruses preparation and adenovirus banks. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed |